Multiplexed immunobead-based assay for detection of oral cancer protein biomarkers in saliva
Objective: For clinical applications of biomarkers, there is a need for multiplex assays using high throughput platforms. The objective of this study was to determine the efficacy of Luminex Multianalyte Profiling (xMAP) technology for measurement of salivary proteins and to evaluate whether multip...
Saved in:
Published in | Oral diseases Vol. 14; no. 8; pp. 705 - 712 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
Oxford, UK
Blackwell Publishing Ltd
01.11.2008
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Objective: For clinical applications of biomarkers, there is a need for multiplex assays using high throughput platforms. The objective of this study was to determine the efficacy of Luminex Multianalyte Profiling (xMAP) technology for measurement of salivary proteins and to evaluate whether multiplex assays are as effective as single‐plex assays and enzyme‐linked immunosorbent assay (ELISA).
Results: The average levels of interleukin‐8 (IL‐8) from the single‐plex assay were 3313.2 ± 3759.8 pg ml−1 [oral squamous cell carcinoma (OSCC), n = 20] and 1061.7 ± 1978.8 pg ml−1 (control, n = 20). The IL‐1β average levels from the single‐plex assay were 945.2 ± 1134.8 pg ml−1 (OSCC, n = 20) and 314.2 ± 444.8 pg ml−1 (control, n = 20). The average levels of IL‐8 from the multiplex assay were 2834.9 ± 3385.6 pg ml−1 (OSCC, n = 20) and 947.3 ± 2036.8 pg ml−1 (control, n = 20). The IL‐1β average levels from the multiplex assay were 1013.5 ± 1221.1 pg ml−1 (OSCC, n = 20) and 376.3 ± 576.3 pg ml−1 (control, n = 20). The correlation coefficient between Luminex and ELISA assay for IL‐8 (n = 19) and IL‐1β (n = 19) was 0.91 and 0.84, respectively.
Conclusion: Luminex xMAP single‐plex and multiplex assays are as effective as ELISA assays for quantification of proteins in saliva. Both IL‐8 and IL‐1β were expressed at significantly higher levels in OSCC subjects than in the matched healthy control subjects. |
---|---|
Bibliography: | ArticleID:ODI1488 ark:/67375/WNG-GB7C8X3M-6 istex:17EDFAFDDFA38F3BCAC8EAE14AC216B86DB530B6 ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 Martha E. Arellano-Garcia contributed to the designing of the experiment, acquisition, analysis and interpretation of the data. She also drafted the paper. She Hu provided his expertise and designed the experiment. He had a major contribution in the analysis and interpretation of data. He also helped draft the paper and critically revised it. Hui Zhou is the statistician who analysed the data and made statistical calculation. Jianghua Wang is the clinician who collected the patient samples and obtained written consent. Bradely Henson is the clinician who helped collect the patient samples. David Chia provided his expertise and knowledge about multiplexing technology and provided the instrument for data acquisition. David T. Wong provided expertise in designing the study and critically revised the manuscript. Author contributions |
ISSN: | 1354-523X 1601-0825 1601-0825 |
DOI: | 10.1111/j.1601-0825.2008.01488.x |